BOLT
Bolt Biotherapeutics, Inc. Common Stock
stockNASDAQ
Market OpenOct 23, 2026 3:31:46 PM EDT
6.44USD+53.699%(+2.25)12,495,764
BOLT Financials
In Q2 FY 2026 (ended ), Bolt Biotherapeutics, Inc. Common Stock (BOLT) reported revenue of $5K, net income of −$7.72M, operating cash flow of −$6.54M, and assets of $40.34M.
Loading financial statements…